Sep 30, 2019 8:35 am EDT Acasti Pharma Announces Additional Phase 3 Milestones Reached, and Remains on Track to Report Topline Results for TRILOGY 1 in December 2019 and TRILOGY 2 in January 2020
Sep 9, 2019 8:30 am EDT Acasti Pharma Receives Funding from the Government of Canada to Expand Production Capacity
Sep 4, 2019 9:00 am EDT Acasti Pharma to Present at the 21st Annual Rodman & Renshaw Global Investment Conference in New York City on September 9th
Aug 28, 2019 4:05 pm EDT Acasti Pharma Announces the Election of Its Directors, Amendments to Its Stock Option and Equity Incentive Plans and Other Related Matters Approved at Its AGM
Aug 9, 2019 8:00 am EDT Acasti Pharma Co-Founder, Chief Operating and Scientific Officer to Participate on Lipid Panel at the 2019 BTIG Biotechnology Conference
Jul 25, 2019 3:42 pm EDT Acasti Pharma Comments on Trading Activity and Reaffirms No Plans to Raise Capital
Jun 24, 2019 9:00 am EDT Acasti Pharma Awarded Notice of Allowance for a Second Patent in China Covering CaPre’s Omega-3 Phospholipid Composition